147 related articles for article (PubMed ID: 15053783)
1. Metoprolol CR/XL improves systolic and diastolic left ventricular function in patients with chronic heart failure.
Hole T; Frøland G; Gullestad L; Offstad J; Skjaerpe T
Echocardiography; 2004 Apr; 21(3):215-23. PubMed ID: 15053783
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal myocardial contraction improves early during titration with metoprolol CR/XL in patients with heart failure.
Andersson B; Sveälv BG; Täng MS; Mobini R
Heart; 2002 Jan; 87(1):23-8. PubMed ID: 11751658
[TBL] [Abstract][Full Text] [Related]
3. Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial.
Colucci WS; Kolias TJ; Adams KF; Armstrong WF; Ghali JK; Gottlieb SS; Greenberg B; Klibaner MI; Kukin ML; Sugg JE;
Circulation; 2007 Jul; 116(1):49-56. PubMed ID: 17576868
[TBL] [Abstract][Full Text] [Related]
4. Metoprolol CR/XL in female patients with heart failure: analysis of the experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Ghali JK; Piña IL; Gottlieb SS; Deedwania PC; Wikstrand JC;
Circulation; 2002 Apr; 105(13):1585-91. PubMed ID: 11927527
[TBL] [Abstract][Full Text] [Related]
5. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
[TBL] [Abstract][Full Text] [Related]
6. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF).
Lancet; 1999 Jun; 353(9169):2001-7. PubMed ID: 10376614
[TBL] [Abstract][Full Text] [Related]
7. Effects of long-term monotherapy with metoprolol CR/XL on the progression of left ventricular dysfunction and remodeling in dogs with chronic heart failure.
Morita H; Suzuki G; Mishima T; Chaudhry PA; Anagnostopoulos PV; Tanhehco EJ; Sharov VG; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2002 Sep; 16(5):443-9. PubMed ID: 12652114
[TBL] [Abstract][Full Text] [Related]
8. Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study.
Goldstein S; Fagerberg B; Hjalmarson A ; Kjekshus J; Waagstein F; Wedel H; Wikstrand J;
J Am Coll Cardiol; 2001 Oct; 38(4):932-8. PubMed ID: 11583861
[TBL] [Abstract][Full Text] [Related]
9. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure.
Groenning BA; Nilsson JC; Sondergaard L; Fritz-Hansen T; Larsson HB; Hildebrandt PR
J Am Coll Cardiol; 2000 Dec; 36(7):2072-80. PubMed ID: 11127443
[TBL] [Abstract][Full Text] [Related]
10. Effects of metoprolol CR/XL on mortality and hospitalizations in patients with heart failure and history of hypertension.
Herlitz J; Wikstrand J; Denny M; Fenster P; Heywood T; Masszi G; Rasmussen S; Thorgeirsson G; Wachtell K;
J Card Fail; 2002 Feb; 8(1):8-14. PubMed ID: 11862577
[TBL] [Abstract][Full Text] [Related]
11. How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF).
Wikstrand J; Wedel H; Ghali J; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F
Card Electrophysiol Rev; 2003 Sep; 7(3):264-75. PubMed ID: 14739726
[TBL] [Abstract][Full Text] [Related]
12. Metoprolol: a review of its use in chronic heart failure.
Prakash A; Markham A
Drugs; 2000 Sep; 60(3):647-78. PubMed ID: 11030472
[TBL] [Abstract][Full Text] [Related]
13. An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.
Batty JA; Hall AS; White HL; Wikstrand J; de Boer RA; van Veldhuisen DJ; van der Harst P; Waagstein F; Hjalmarson Å; Kjekshus J; Balmforth AJ;
Clin Pharmacol Ther; 2014 Mar; 95(3):321-30. PubMed ID: 24193112
[TBL] [Abstract][Full Text] [Related]
14. Rationale, design, and organization of the Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF). The International Steering Committee.
Am J Cardiol; 1997 Nov; 80(9B):54J-58J. PubMed ID: 9375952
[TBL] [Abstract][Full Text] [Related]
15. Effects of long-term adrenergic beta-blockade on left ventricular diastolic filling in patients with acute myocardial infarction.
Poulsen SH; Jensen SE; Egstrup K
Am Heart J; 1999 Oct; 138(4 Pt 1):710-20. PubMed ID: 10502218
[TBL] [Abstract][Full Text] [Related]
16. Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HF.
Jánosi A; Ghali JK; Herlitz J; Czuriga I; Klibaner M; Wikstrand J; Hjalmarson A;
Am Heart J; 2003 Oct; 146(4):721-8. PubMed ID: 14564329
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
[TBL] [Abstract][Full Text] [Related]
18. Improvement of exercise capacity and left ventricular diastolic function with metoprolol XL after acute myocardial infarction.
Poulsen SH; Jensen SE; Egstrup K
Am Heart J; 2000 Jul; 140(1):E6-11. PubMed ID: 10874255
[TBL] [Abstract][Full Text] [Related]
19. MERIT-HF mortality and morbidity data.
Hjalmarson A; Fagerberg B
Basic Res Cardiol; 2000; 95 Suppl 1():I98-103. PubMed ID: 11192362
[TBL] [Abstract][Full Text] [Related]
20. Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy.
Ghio S; Magrini G; Serio A; Klersy C; Fucili A; Ronaszèki A; Karpati P; Mordenti G; Capriati A; Poole-Wilson PA; Tavazzi L;
Eur Heart J; 2006 Mar; 27(5):562-8. PubMed ID: 16443607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
